Free Newsletter
Pain drug prescriptions skyrocket
Use of prescription pain pills has skyrocketed over the past several years, according to a government study. Sales of the five biggest painkillers--codeine, morphine, oxycodone, hydrocodone and meperidine--jumped by 90 percent between 1997 and 2005. But it's oxycodone (OxyContin) that's responsible for much of that growth; sales of that compound grew almost six-fold during the same period. OxyContin is made by Perdue Pharma; the next-leading drug, hydrocodone/Vicodin, is made by Abbott Laboratories. Both drugs have generic competitors sold under different trade names as well.
The study was undertaken by the Drug Enforcement Administration, which was looking for illegal prescription patterns. But according to the Associated Press, the growth in painkiller use has some perfectly legal reasons behind it. The population is getting older, and older people use more pain medication. Drug marketing has spurred more patients to seek pain relief. And whereas doctors once considered pain to be part of healing, now it's pain management that's seen as key to overcoming illness.
- read the report from The Washington Post
Related Articles:
Pain management debate in focus. Report
Purdue execs plead guilty to OxyContin fraud. Report
Purdue slashes work force as generic OxyContin gets green light. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession






SHARE
WITH: